|
Parameters
|
Subacute phase
|
Subchronic phase
|
|---|
|
Treatment group
|
Control
|
P value
|
Treatment group
|
Control
|
P value
|
|---|
|
Number of animals analyzed
|
12
|
12
|
12
|
11
|
|---|
|
WBCs (× 103/μl)
|
8.55 ± 2.12
|
8.23 ± 1.65
|
0.68
|
9.0 ± 1.96
|
8.03 ± 1.33
|
0.18
|
|
RBCs (× 106/μl)
|
6.50 ± 0.68
|
6.31 ± 0.62
|
0.49
|
6.41 ± 0.51
|
6.21 ± 0.53
|
0.38
|
|
HGB (g/dl)
|
12.56 ± 0.37
|
12.46 ± 0.74
|
0.68
|
12.52 ± 0.76
|
12.18 ± 0.50
|
0.22
|
|
HCT (%)
|
36.56 ± 1.05
|
34.62 ± 4.73
|
0.19
|
33.25 ± 2.48
|
32.63 ± 2.81
|
0.58
|
|
MCV (fl)
|
52.72 ± 4.03
|
52.18 ± 3.24
|
0.72
|
50.62 ± 1.77
|
50.24 ± 1.60
|
0.59
|
|
MCH (pg)
|
20.52 ± 1.28
|
20.12 ± 1.98
|
0.56
|
19.71 ± 1.02
|
19.78 ± 1.29
|
0.89
|
|
MCHC (g/dl)
|
37.15 ± 2.64
|
37.04 ± 2.36
|
0.91
|
38.94 ± 1.88
|
39.20 ± 1.68
|
0.73
|
|
PLT (103/μl)
|
472.16 ± 29.44
|
471.31 ± 43.55
|
0.95
|
531.50 ± 125.49
|
545.0 ± 110.63
|
0.78
|
|
RDW (%)
|
12.45 ± 1.01
|
12.65 ± 1.34
|
0.67
|
11.33 ± 0.92
|
11.03 ± 0.82
|
0.42
|
|
Reticulocytes (%)
|
0.97 ± 0.43
|
1.04 ± 0.54
|
0.74
|
1.10 ± 0.22
|
1.04 ± 0.03
|
0.39
|
- IV intravenous; BM-cMSC bone marrow-derived mesenchymal stromal cells; WBCs white blood cells; RBCs red blood cells; HGB hemoglobin; HCT hematocrit; MCV mean corpuscular volume; MCH mean corpuscular hemoglobin; MCHC mean corpuscular hemoglobin concentration; PLT platelets; RDW-CV red blood cell distribution width coefficient variation. P ≤ 0.05 indicates statistical significance
